Centricity Research, an integrated research organization, has appointed Will Furness chief executive officer and Mike Petit as chief financial officer. Furness replaces Dr. Jeff Kingsley, who has taken on a new role as chief corporate development officer.

Furness will work closely with new CFO Petit, who will oversee all of Centricity Research’s financial functions and build a strong financial platform to support the company’s growth trajectory, including strategic planning, forecasting, accounting, tax, and treasury mandates.

Furness joins Centricity Research from Thriveworks, a national multisite healthcare practice with more than 350 locations, where he was CEO. Prior to that, he held senior positions in multisite healthcare services at Dartmouth College, Sound Physicians, and Vein Clinics of America (VCA).

Prior to Centricity Research, Petit served as CFO of multiple high-growth healthcare organizations, including ConvenientMD Urgent Care, APDerm and Claris Vision. Most recently, he was CFO of Novocardia, North America’s first private equity backed cardiology group, where he helped to significantly scale the organization, while expanding into new lines of service, including value-based care.

“As Centricity Research embarks on our next phase of growth, I’m thrilled to turn over the reins to Will, who has a strong track record of successfully scaling up businesses,” said Kingsley. “Will has spent his career dedicated to improving experiences, outcomes and support care teams for patients, and we’re excited to bring his proven approach to our organization.”

“I’m proud that Centricity was one of the most prominent site networks to help bring COVID-19 vaccines to market during the pandemic,” Furness said, emphasizing that the organization has a passion for revolutionizing research supported by the deepest clinical expertise of any company in North America. “Our team will continue to grow and innovate across all therapeutic areas to be the partner of choice for pharmaceutical companies, while providing the best experience for patients who want to help us revolutionize medicine.”

“The opportunities are abundant at Centricity Research, and we need to grow in a way that aligns with the increasingly complex needs of our industry, while remaining focused on bringing life-saving therapies to our community,” Petit said.